HealthEquity HQY Interchange revenue — Total Cost of Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about HealthEquity's interchange revenue — total cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is HealthEquity's interchange revenue — total cost of revenue?
- HealthEquity (HQY) reported interchange revenue — total cost of revenue of $8.35M in Q1 2026.
- How has HealthEquity's interchange revenue — total cost of revenue changed year-over-year?
- HealthEquity's interchange revenue — total cost of revenue increased by 7.3% year-over-year, from $7.78M to $8.35M.
- What is the long-term trend for HealthEquity's interchange revenue — total cost of revenue?
- Over 4 years (2022 to 2026), HealthEquity's interchange revenue — total cost of revenue has grown at a 7.9% compound annual growth rate (CAGR), from $20.68M to $27.99M.
- What does interchange revenue — total cost of revenue mean?
- This metric captures the direct costs associated with facilitating payment card transactions, including network processing fees, card issuance expenses, and related operational support costs. It serves as a measure of the variable expenses required to maintain and scale the company's payment processing infrastructure. Monitoring this cost relative to interchange revenue helps assess the operational efficiency and direct profitability of the payment services segment.